Form 8-K - Current report:
SEC Accession No. 0001104659-23-080348
Filing Date
2023-07-12
Accepted
2023-07-12 16:31:48
Documents
13
Period of Report
2023-07-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2321174d1_8k.htm   iXBRL 8-K 26656
2 EXHIBIT 99.1 tm2321174d1_ex99-1.htm EX-99.1 17018
  Complete submission text file 0001104659-23-080348.txt   222657

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cyrx-20230712.xsd EX-101.SCH 3283
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cyrx-20230712_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cyrx-20230712_pre.xml EX-101.PRE 22359
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2321174d1_8k_htm.xml XML 3297
Mailing Address 112 WESTWOOD PLACE, SUITE 350 BRENTWOOD TN 37027
Business Address 112 WESTWOOD PLACE, SUITE 350 BRENTWOOD TN 37027 (949) 232-1900
Cryoport, Inc. (Filer) CIK: 0001124524 (see all company filings)

EIN.: 880313393 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34632 | Film No.: 231085019
SIC: 2834 Pharmaceutical Preparations